| Autor: |
Leandro Mendonça, Lindner, Antonio Carlos, Marasciulo, Mareni Rocha, Farias, Geder Evandro Motta, Grohs |
| Rok vydání: |
2008 |
| Předmět: |
|
| Zdroj: |
Revista de saude publica. 43 |
| ISSN: |
1518-8787 |
| Popis: |
To assess the cost-utility of first and second-generation antipsychotics for treatment of schizophrenia.A five-year Markov model was constructed based on a survey of the records of patients seen in 2006 at a psychosocial care center in the municipality of Florianopolis, Southern Brazil. Costs were evaluated from the perspective of the Sistema Unico de Saúde (SUS - Unified Healthcare System). Utility was measured in quality-adjusted life years obtained in the literature.The Markov model indicated risperidone and haloperidol utilization before olanzapine as the most cost-effective alternatives.Antipsychotic agents haloperidol and risperidone are more cost-effective than olanzapine. Strategies prioritizing the use of antipsychotics with better cost-effectiveness could optimize resource allocation without necessarily compromising the health of patients treated through the Sistema Unico de Saúde. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
